Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
5.28
+0.43 (8.87%)
At close: Oct 19, 2026, 4:00 PM EDT
5.28
0.00 (0.00%)
After-hours: Oct 19, 2026, 4:00 PM EDT
Kyntra Bio Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Kyntra Bio stock has a consensus rating of "Buy" and an average price target of $38.5. The average 1-year stock price forecast is 629.17% higher than the current stock price, while the lowest is $35 (+562.88%) and the highest is $43 (+714.39%).
Price Target: $38.5 (+629.17%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kyntra Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Initiates $35 | Buy | Initiates | $35 | +562.88% | Oct 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $43 | Buy | Reiterates | $43 | +714.39% | Oct 5, 2026 |
| Lake Street | Lake Street | Buy Initiates $41 | Buy | Initiates | $41 | +676.52% | Sep 17, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 | Buy | Maintains | $35 | +562.88% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
6.42M
from 6.44M
Decreased by -0.27%
Revenue Next Year
7.33M
from 6.42M
Increased by 14.12%
EPS This Year
-12.41
from 45.37
EPS Next Year
-14.23
from -12.41
EPS and Forward PE are based on non-GAAP adjusted numbers.